Health & Environmental Research Online (HERO)


Print Feedback Export to File
1028618 
Journal Article 
Arsenic induces telomerase expression and maintains telomere length in human cord blood cells 
Ferrario, D; Collotta, A; Carfi, M; Bowe, G; Vahter, M; Hartung, T; Gribaldo, L 
2009 
Toxicology
ISSN: 0300-483X
EISSN: 1879-3185 
260 
1-3 
132-141 
English 
Inorganic arsenic (iAs) is a human carcinogen, well known as a clastogenic compound. To evaluate the molecular mechanism of arsenite (iAs(III)) toxicity, we investigated the effects on cell growth and apoptosis, telomere length, telomerase expression, as well as the formation of reactive oxygen species (ROS) in male and female human cord blood cells in vitro. Incubation with iAs(III) at the concentration of 0.0001 microM increased telomerase mRNA and protein expression maintained both telomere length and cellular growth, and induced mRNA over-expression of the two oncogenes ras and myc. Our results suggest that female cord blood cells are more sensitive than male ones to iAs(III) induced telomerase stimulation at low concentrations, possibly related to the increased expression of ras and myc oncogenes. On the contrary, at the concentration of 1 microM, iAs(III) decreased telomerase expression and telomere length, and induced apoptosis, necrosis and production of reactive oxygen species. Buthionine sulfoximine (BSO), an inhibitor of glutathione (GSH) synthesis, markedly increased the percentage of apoptotic cells, suggesting that GSH is fundamental for detoxification of iAs(III) in cord blood cells. The reactive oxygen species (ROS) scavenger, 5,5-dimethyl-1-pyrroline-N-oxide (DMPO), protected cord blood cells from iAs(III) toxicity, and prevented telomere shortening and telomerase down-modulation. It can be concluded that telomerase expression and telomere length are associated with iAs(III) induced cell death, via production of reactive oxygen species, as well as with iAs(III) induced effects on cell differentiation processes and rate of cell growth. 
In vitro; Arsenic; hTERT; ROS; BSO; DMPO 
• Arsenic (Inorganic)
     1. Literature
          PubMed
          Toxline, TSCATS, & DART
          Web of Science
          Identified during manual review of authoritative sources
     3. Hazard ID Screening
          Other potentially supporting studies
     4. Adverse Outcome Pathways/Networks Screening
          Relevant
     5. Susceptibility Screening
          Excluded/Not relevant
• Arsenic MOA
     4. Adverse Outcome Pathways
          Cell viability, cell proliferation, cell cycle changes (unrelated to regenerative proliferation)
          Oxidative stress related effects (includes non-specific SH reactions)
     5. Health Effect
          Hematology, Hematopoietic System
          Cancer
     1. MOA Literature Screening
          MOA Cluster
          Susceptibility Screening
• Arsenic Susceptibility
     5. Health Effect
          Not Relevant
     1. Susceptibility Literature Screening
          Supplemental Search
     2. Excluded
          MOA/Mechanistic
     3. References Identified During Review
     Life Stages Citation Mapping
          5%-10%
• Inorganic Arsenic (7440-38-2) [Final 2025]
     1. Initial Lit Search
          PubMed
          WOS
          ToxNet
     4. Considered through Oct 2015
     6. Cluster Filter through Oct 2015
     7. Other Studies through Oct 2015
          MOA
          iAs MOA Literature Categorization
               Cytotoxicity and Regenerative Proliferation
               Epigenetic Mechanisms
               Immune